What's new

[Cyprus Times] These are the two drugs recommended by the WHO for the treatment of Ebola

1-425-600x410-1.jpg

These are the two drugs recommended by the WHO to treat Ebola Revolution in the treatment of a disease once thought to cause almost certain death

The World Health Organization (WHO) today recommended the use of two monoclonal antibody preparations against Ebola, saying that the administration of these drugs combined with better care have revolutionised "the treatment of a disease once thought to cause almost certain death".

It is the first time the World Health Organization has made recommendations for treatments for Ebola.[BR]

The drugs - Regeneron's Inmazeb and Ridgeback's Ebanga (mAb114) - use laboratory-made monoclonal antibodies that mimic natural antibodies to fight infections.

"Advances in supportive care and pharmacotherapeutic formulations over the past decade have revolutionized the treatment of Ebola. Ebola virus disease was once thought to cause almost certain death. However, this is no longer the case," said Robert Fowler, a professor at the University of Toronto in Canada and co-chair of the WHO Health Guideline Development Team.

Effective care and use of these drugs is now leading to the recovery of the 'vast majority' of people from Ebola, he said, without giving specific figures.

The new recommendations follow trials of drugs against hemorrhagic fever in the Democratic Republic of Congo during the 2018-2020 outbreak there. Dr Janet Diaz, head of the clinical management unit of the Health Emergencies Programme of the WHO Health Programme, told reporters that the drugs are now available in DR Congo, but more work needs to be done to improve accessibility.

"Access roads are a priority for work at the moment," he said."

SOURCE: Cyprus Times
Contents of this article including associated images are belongs Cyprus Times
Views & opinions expressed are those of the author and/or Cyprus Times

Source

 
Back
Top